Business
InMode Expects Record Third Quarter 2022 Revenue of $120.5M-$120.9M, Raising Full-Year 2022 Revenue Guidance to $445M-450M
Conference call to be held on Thursday, October 27, 2022, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 13, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD),
About this update from Inmode Ltd.
[{"type":"text","content":"Conference call to be held on Thursday, October 27, 2022, at 8:30 a.m. Eastern Time\nYOKNEAM, Israel, Oct. 13, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2022 before the Nasdaq market opens on Thursday, October 27, 2022.\n \nInMode is currently finalizing its financial results for the third quarter of 2022. While complete financial information and operating data are not yet available, set forth below are certain preliminary financial results for said period, subject to final adjustments and other developments that may arise between now and the time such financial results are published. Based on preliminary Q3 2022 results, management expects:\nRecord revenue for the third quarter of 2022 to be in the range of $120.5 million to $120.9 millionNon-GAAP1 gross margin for the third quarter of 2022 to be in the range of 84% to 85%Record Non-GAAP1 earnings per diluted share for the third quarter of 2022 to be in the range of $0.64 to $0.65Revenue for the full year of 2022 to be in the range of $445 million to $450 million1Please refer to \"Use of Non-GAAP Financial Measures\" below for important information about non-GAAP financial measures. Non-GAAP financial results exclude share-based compensation adjustments.\nInMode will host a conference call to discuss the third quarter 2022 financial results on October 27, at 8:30 a.m. Eastern Time with presentations from management including Moshe Mizrahy, Chairman and Chief Executive Officer; Yair Malca, Chief Financial Officer; Dr. Michael Kreindel, Chief Technology Officer; Shakil Lakhani, President of North America; and Dr. Spero Theodorou, Chief Medical Officer.\nThe Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10171927/f4b117e67a. Callers will receive a unique dial-in upon registration, which enables immediate access on the day of the call. Participants may pre-register at any time, including up to and after the call start time.\nFor callers that opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the ...